Related Experiment Video
Updated: Jul 17, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Decreased cell surface prion protein in mouse models of prion disease
Jennifer K Griffin1, Linda A Terry, Roy Jackman
1Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, Ontario, Canada.
Abstract:
Transmissible spongiform encephalopathies are infectious neurodegenerative diseases caused by prions, composed of ordered aggregates of misfolded cellular prion protein. Neural antigen density of prion protein, Thy-1 and glial fibrillary acidic protein was analyzed using flow cytometry of dissociated mouse brain cells after inoculation with mouse-adapted transmissible spongiform encephalopathy agents. Transmissible spongiform encephalopathy gliosis was demonstrated by increased intracellular immunoreactivity for glial fibrillary acidic protein compared with controls. Immunoreactivity for cell surface prion protein was reduced 2.8-3.8-fold compared with control brain cells, whereas surface Thy-1 protein was reduced 1.5-4-fold. Double-staining protocols revealed loss of brain cells highly immunoreactive for prion protein and Thy-1, with a preferential reduction of prion protein, suggesting that prion protein expression, trafficking or consumption may be affected early in disease.
Insights
Transmissible spongiform encephalopathies (TSEs) reduce cell surface prion protein and Thy-1 levels in mouse brains. This suggests early alterations in prion protein expression or trafficking during TSE disease progression.
Area of Science:
- Neuroscience
- Prion Biology
- Cellular Immunology
Background:
- Transmissible spongiform encephalopathies (TSEs) are fatal neurodegenerative diseases.
- These diseases are caused by prions, which are misfolded prion proteins.
- Prions form aggregates that damage brain tissue.
Purpose of the Study:
- To analyze neural antigen density in mouse brains affected by TSEs.
- To investigate changes in prion protein (PrP), Thy-1, and glial fibrillary acidic protein (GFAP).
- To understand early molecular events in TSE pathogenesis.
Main Methods:
- Flow cytometry was used to analyze dissociated mouse brain cells.
- Mice were inoculated with mouse-adapted TSE agents.
- Immunoreactivity for PrP, Thy-1, and GFAP was quantified.
Main Results:
- TSE infection induced gliosis, indicated by increased intracellular GFAP.
- Cell surface PrP immunoreactivity decreased 2.8-3.8-fold.
- Surface Thy-1 protein levels decreased 1.5-4-fold.
- Loss of brain cells expressing high levels of PrP and Thy-1 was observed.
Conclusions:
- TSEs cause significant reductions in cell surface PrP and Thy-1.
- Preferential reduction of PrP suggests early disease-related changes.
- Prion protein expression, trafficking, or consumption may be altered early in TSEs.

